Ignite Creation Date:
2024-05-06 @ 8:22 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06356259
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2024-04-04
Brief Title:
A Study to Evaluate the Safety Tolerability and Pharmacokinetics Following Intravenous Administration of IRX-010 in Healthy Participants
Sponsor:
ImmunoRx Pharma Inc
Organization:
ImmunoRx Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-07
Start Date Type:
ACTUAL
Primary Completion Date:
2025-01-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-01-22
Completion Date Type:
ESTIMATED
First Submit Date:
2024-04-04
First Submit QC Date:
April 4 2024
Study First Post Date:
2024-04-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-24
Last Update Post Date:
2024-04-15
Last Update Post Date Type:
ACTUAL